SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-22-000007
Filing Date
2022-05-09
Accepted
2022-05-09 09:22:38
Documents
63
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avdl-20220331.htm   iXBRL 10-Q 1070313
2 EX-31.1 exhibit311q12022.htm EX-31.1 10952
3 EX-31.2 exhibit312q12022.htm EX-31.2 10772
4 EX-32.1 exhibit321q12022.htm EX-32.1 5531
5 EX-32.2 exhibit322q12022.htm EX-32.2 5346
  Complete submission text file 0001012477-22-000007.txt   4993974

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20220331.xsd EX-101.SCH 31790
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20220331_cal.xml EX-101.CAL 70163
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20220331_def.xml EX-101.DEF 139251
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20220331_lab.xml EX-101.LAB 393364
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20220331_pre.xml EX-101.PRE 263695
57 EXTRACTED XBRL INSTANCE DOCUMENT avdl-20220331_htm.xml XML 812932
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 22903487
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences